- Home
- ALLE vs NBIX Comparison
ALLE vs NBIX Comparison
Compare ALLE & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLE
- NBIX
- Stock Information
- Founded
- ALLE 2013
- NBIX 1992
- Country
- ALLE Ireland
- NBIX United States
- Employees
- ALLE N/A
- NBIX N/A
- Industry
- ALLE Diversified Commercial Services
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALLE Consumer Discretionary
- NBIX Health Care
- Exchange
- ALLE Nasdaq
- NBIX Nasdaq
- Market Cap
- ALLE 15.4B
- NBIX 14.4B
- IPO Year
- ALLE N/A
- NBIX 1996
- Fundamental
- Price
- ALLE $161.86
- NBIX $144.77
- Analyst Decision
- ALLE Hold
- NBIX Strong Buy
- Analyst Count
- ALLE 9
- NBIX 18
- Target Price
- ALLE $172.22
- NBIX $172.33
- AVG Volume (30 Days)
- ALLE 798.2K
- NBIX 1.1M
- Earning Date
- ALLE 10-23-2025
- NBIX 10-28-2025
- Dividend Yield
- ALLE 1.27%
- NBIX N/A
- EPS Growth
- ALLE 13.70
- NBIX 12.44
- EPS
- ALLE 7.39
- NBIX 4.19
- Revenue
- ALLE $3,979,700,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- ALLE $10.07
- NBIX $23.68
- Revenue Next Year
- ALLE $6.55
- NBIX $18.02
- P/E Ratio
- ALLE $21.82
- NBIX $34.56
- Revenue Growth
- ALLE 6.87
- NBIX 19.61
- 52 Week Low
- ALLE $116.57
- NBIX $84.23
- 52 Week High
- ALLE $180.68
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- ALLE 32.93
- NBIX 50.90
- Support Level
- ALLE $164.69
- NBIX $145.00
- Resistance Level
- ALLE $169.45
- NBIX $148.84
- Average True Range (ATR)
- ALLE 2.89
- NBIX 5.31
- MACD
- ALLE -0.28
- NBIX -0.33
- Stochastic Oscillator
- ALLE 12.50
- NBIX 47.17
About ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.